Dalton, Greiner, Hartman, Maher & Co’s Patterson-UTI PTEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PTEN
Dalton, Greiner, Hartman, Maher & Co's PTEN Position: Q3 2019 in Review
Dalton, Greiner, Hartman, Maher & Co sold out of Patterson-UTI (PTEN) in Q3 2019, closing a stake of 186,735 shares — an estimated $2.15M sold.
Dalton, Greiner, Hartman, Maher & Co first reported a position in PTEN in Q2 2013 and held it in 20 quarters. The position peaked at $17M in Q4 2015. 268 funds tracked by Wall St. Rank hold PTEN as of Q3 2019.
- Dalton, Greiner, Hartman, Maher & Co reported no remaining Patterson-UTI position as of Q3 2019 after selling out during the quarter.
- Dalton, Greiner, Hartman, Maher & Co sold 186,735 Patterson-UTI shares in Q3 2019, an estimated $2.15M.
- Dalton, Greiner, Hartman, Maher & Co first reported a position in Patterson-UTI in Q2 2013 and held it in 20 quarters.
- Dalton, Greiner, Hartman, Maher & Co's Patterson-UTI position peaked at $17M in Q4 2015.
- 268 funds tracked by Wall St. Rank held Patterson-UTI as of Q3 2019.
Based on Dalton, Greiner, Hartman, Maher & Co's 13F filing for Q3 2019, filed 10 Oct 2019.